What is CycloPure?
Cyclopure, Inc. is at the forefront of combating PFAS contamination in water systems. The company has developed DEXSORB, a proprietary renewable adsorbent engineered for the effective removal of per- and polyfluoroalkyl substances (PFAS). Their product portfolio includes user-friendly test kits and advanced filters suitable for both domestic and large-scale engineered applications. By focusing on water health as a fundamental component of human well-being, CycloPure aims to tackle the global public health challenge posed by PFAS, offering a vital service to individuals and communities seeking to ensure the safety of their water supply.
How much funding has CycloPure raised?
CycloPure has raised a total of $4.2M across 2 funding rounds:
Series B
$4M
Debt
$181K
Series B (2019): $4M with participation from Undisclosed
Debt (2021): $181K led by PPP
Key Investors in CycloPure
Undisclosed Investors
PPP
Public-Private Partnership
What's next for CycloPure?
The substantial enterprise-level backing and recent strategic investment position CycloPure for significant expansion and technological advancement. This capital infusion is likely to fuel further research and development into PFAS removal technologies, enhance manufacturing capabilities for DEXSORB, and broaden market penetration. CycloPure's commitment to addressing a critical environmental and health issue suggests a trajectory focused on scaling its impact and solidifying its position as a leader in water purification, potentially exploring new applications and partnerships to combat the pervasive challenge of PFAS contamination.
See full CycloPure company page
